Neo Corporate Pcl vs LOréal: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Neo Corporate Pcl (NEO.BK)

Q3 202614 Aug – 18 Sep 2026

▲3

NEO's profit surge and stimulus extension keep growth story alive

Q2 profit jumps 161%, sales hit record NEO's second-quarter profit surged 161% to 209 million baht, with record sales of 3.05 billion baht, up 18% from a year earlier. The company raised its full-year sales growth target to double digits, showing strong momentum in household and personal care products.
This is the core earnings event that shows the company's fundamental strength and supports the stock's value.
Government stimulus extension to boost Q4 demand Thailand's cabinet approved a two-month extension of the Thai Chai Thai Plus co-payment scheme, injecting up to 70 billion baht into the economy. NEO is named a top beneficiary because its consumer products are sold through traditional retail channels used by the program's 40 million recipients.
This directly supports NEO's domestic sales and profit in the fourth quarter, a key driver of future earnings.
Brokers raise targets, see profit growth ahead Dao Securities maintains a Buy rating with a 31 baht target, expecting 2026 profit to grow 14% to 642 million baht. It notes the stock trades at only 11.2 times earnings, below its historical average, and does not yet reflect the profit recovery trend.
Analyst upgrades and attractive valuation can draw investor attention and support the share price.

August 202614 Aug – 18 Sep 2026

▲3

NEO's profit surge and stimulus extension keep growth story alive

Q2 profit jumps 161%, sales hit record NEO's second-quarter profit surged 161% to 209 million baht, with record sales of 3.05 billion baht, up 18% from a year earlier. The company raised its full-year sales growth target to double digits, showing strong momentum in household and personal care products.
This is the core earnings event that shows the company's fundamental strength and supports the stock's value.
Government stimulus extension to boost Q4 demand Thailand's cabinet approved a two-month extension of the Thai Chai Thai Plus co-payment scheme, injecting up to 70 billion baht into the economy. NEO is named a top beneficiary because its consumer products are sold through traditional retail channels used by the program's 40 million recipients.
This directly supports NEO's domestic sales and profit in the fourth quarter, a key driver of future earnings.
Brokers raise targets, see profit growth ahead Dao Securities maintains a Buy rating with a 31 baht target, expecting 2026 profit to grow 14% to 642 million baht. It notes the stock trades at only 11.2 times earnings, below its historical average, and does not yet reflect the profit recovery trend.
Analyst upgrades and attractive valuation can draw investor attention and support the share price.

Latest14 Aug – 18 Sep 2026

▲3

NEO's profit surge and stimulus extension keep growth story alive

Q2 profit jumps 161%, sales hit record NEO's second-quarter profit surged 161% to 209 million baht, with record sales of 3.05 billion baht, up 18% from a year earlier. The company raised its full-year sales growth target to double digits, showing strong momentum in household and personal care products.
This is the core earnings event that shows the company's fundamental strength and supports the stock's value.
Government stimulus extension to boost Q4 demand Thailand's cabinet approved a two-month extension of the Thai Chai Thai Plus co-payment scheme, injecting up to 70 billion baht into the economy. NEO is named a top beneficiary because its consumer products are sold through traditional retail channels used by the program's 40 million recipients.
This directly supports NEO's domestic sales and profit in the fourth quarter, a key driver of future earnings.
Brokers raise targets, see profit growth ahead Dao Securities maintains a Buy rating with a 31 baht target, expecting 2026 profit to grow 14% to 642 million baht. It notes the stock trades at only 11.2 times earnings, below its historical average, and does not yet reflect the profit recovery trend.
Analyst upgrades and attractive valuation can draw investor attention and support the share price.

LOréal S.A. (OR.PA)

Q3 202618 Jun – 30 Jul 2026

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.
This is the core earnings event that directly drives investor confidence and valuation.
Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.
It confirms the growth trend and shows demand is holding up in key regions.
Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.
It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.
Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.
These deals show management actively deploying capital for future growth.

July 202618 Jun – 30 Jul 2026

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.
This is the core earnings event that directly drives investor confidence and valuation.
Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.
It confirms the growth trend and shows demand is holding up in key regions.
Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.
It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.
Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.
These deals show management actively deploying capital for future growth.

Latest18 Jun – 30 Jul 2026

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.
This is the core earnings event that directly drives investor confidence and valuation.
Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.
It confirms the growth trend and shows demand is holding up in key regions.
Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.
It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.
Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.
These deals show management actively deploying capital for future growth.